Vorizol Tablet 200 mg contains Voriconazole 200 mg, a potent broad-spectrum antifungal agent from the triazole class. It is specifically designed for the treatment of severe fungal infections in adults, including invasive aspergillosis, systemic candidiasis, and other life-threatening mycoses.
Voriconazole works by disrupting the fungal cell membrane, inhibiting growth and promoting fungal cell death. Vorizol Tablet 200 mg offers a convenient oral therapy for serious fungal infections, making it suitable for patients who require high-dose antifungal treatment or continuation of therapy outside hospital settings.
Voriconazole 200 mg per tablet
Voriconazole in Vorizol Tablet 200 mg acts by:
Inhibition of fungal cytochrome P450 enzyme (14α-sterol demethylase) – Blocks the conversion of lanosterol to ergosterol, an essential component of the fungal cell membrane.
Disruption of fungal cell membrane synthesis – Causes increased permeability, leading to fungal cell death.
Fungistatic and fungicidal activity – Depending on the fungal species and drug concentration, it can stop growth or directly kill fungi.
Broad-spectrum antifungal coverage – Effective against Aspergillus spp., Candida spp., Fusarium spp., and Scedosporium spp.
Rapid tissue penetration – Achieves therapeutic levels in plasma, lungs, liver, CNS, and eyes, allowing treatment of systemic and invasive infections.
This mechanism makes Vorizol 200 mg highly effective in critical care, oncology, and immunocompromised patients.
Vorizol Tablet 200 mg is indicated for:
Invasive aspergillosis – In immunocompromised and critically ill patients
Severe candidiasis – Including systemic or refractory infections
Fusarium and Scedosporium infections – When alternative antifungal therapy is insufficient
Prophylaxis of fungal infections – In high-risk patients, such as those undergoing stem cell transplantation or chemotherapy
Other serious systemic fungal infections – As determined by a qualified physician
Adults: Typically 200 mg every 12 hours for standard therapy; initial loading doses may be 400 mg every 12 hours for the first 24 hours as prescribed.
Administration: Swallow tablets whole with water; may be taken with or without food.
Monitoring: Periodic assessment of liver function tests, renal function, plasma drug levels, and ECG is recommended during prolonged therapy.
Duration: Based on the type and severity of infection; therapy can last weeks to months.
Adjustment: Required in patients with hepatic impairment or concomitant medications affecting CYP450 enzymes.
Broad-spectrum activity against life-threatening fungal infections
Effective for both treatment and prophylaxis in high-risk patients
Rapid tissue penetration for systemic and CNS infections
Convenient oral formulation for outpatient therapy
Supports improved patient outcomes in immunocompromised and critically ill populations
Use with caution in hepatic impairment, renal dysfunction, or cardiac arrhythmias
Pregnancy and breastfeeding: Only use if clearly indicated
Avoid co-administration with drugs that prolong QT interval or strongly inhibit CYP450
Monitor for hepatotoxicity, visual disturbances, and neurological effects
Adhere to prescribed dosing to prevent resistance or treatment failure
Common side effects:
Nausea, vomiting, diarrhea
Headache and dizziness
Visual disturbances (blurred vision, color changes)
Mild liver enzyme elevation
Serious side effects:
Severe hepatotoxicity
Cardiac arrhythmias due to QT prolongation
Allergic reactions (rash, swelling, or difficulty breathing)
Immediate medical attention is required for liver dysfunction, vision changes, or severe allergic reactions.
Store below 25°C in a cool, dry place
Protect from light and moisture
Keep tablets in original packaging until use
Keep out of reach of children
Vorizol Tablet 200 mg provides powerful antifungal therapy for severe systemic infections, ensuring rapid action, broad coverage, and convenient oral administration for critically ill or immunocompromised patients.
Login Or Registerto submit your questions to seller
No none asked to seller yet